Brendan O'Leary is Director at Trius Therapeutics Inc (TSRX). They have made 1 open-market trade across 1 company since 2014, most recently 2014-10-27.
CIK 0001500269
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $832K since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRTO | BUY | 2014-10-27 | 2014-10-29 | $10.00 | $832K | -29.4% | -6.4% | -6.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.